From excess adiposity to insulin resistance: The role of free fatty acids

Vascular Pharmacology

Volumn 57, Issue 2-4, 2012, Pages 91-97

  Capurso, Cristiano ^a   Capurso, Antonio ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cytokines; Diabetes; FFA; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; FATTY ACID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; TRANSFORMING GROWTH FACTOR ALPHA; TYROSINE; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; AUTOPHOSPHORYLATION; CALORIC INTAKE; ENDOTHELIUM CELL; FIBROBLAST; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; MACROPHAGE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPOLYSIS; OBESITY; RECEPTOR, INSULIN;

EID: 84865422248     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.05.003     Document Type: Review

References (78)

1. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277:1531-1537.
2. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 2003, 14:137-145.
3. Avogaro P., Crepaldi G., Enzi G., Tiengo A. Association of hyperlipidemia, diabetes mellitus and mild obesity. Acta Diabetol. Lat. 1967, 4:572-590.
4. Bays H.E. Adiposopathy. Is "sick fat" a cardiovascular disease?. J. Am. Coll. Cardiol. 2011, 57:2461-2473.
5. Bays H., Ballantyne C. Adiposopathy: why do adiposopathy and obesity cause metabolic disease?. Future Lipidol. 2006, 1:389-420.
6. Bays H.E., González-Campoy J.M., Bray G.A., Kitabchi A.E., Bergman D.A., Schorr A.B., Rodbard H.W., Henry R.R. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 2008, 6:343-368.
7. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
8. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
9. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., Coleman E., Smith C. Effects of fat on insulin stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 1991, 88:960-966.
10. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
11. Clement K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C.A., Sicard A., Rome S., Benis A., Zucker J.D., Vidal H., Laville M., Barsh G.S., Basdevant A., Stich V., Cancello R., Langin D. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004, 18:1657-1669.
12. Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., Van Pelt R.E., Wang H., Eckel R.H. The metabolic syndrome. Endocr. Rev. 2008, 29:777-822.
13. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat. Genet. 2000, 26:13.
14. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
15. DeFronzo R.A., Ferrannini E., Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am. J. Med. 1983, 74:52-81.
16. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
17. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 1983, 72:1737-1747.
18. Festa A., D'Agostino R., Williams K., Karter A.J., Mayer-Davis E.J., Tracy R.P., Haffner S.M. The relation of body fat mass and distribution to markers of chronic inflammation. Int. J. Obes. 2001, 25:1407-1415.
19. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
20. Gao Z., Zhang X., Zuberi A., Hwang D., Quon M.J., Lefevre M., Ye J. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol. 2004, 18:2024-2034.
21. Giorgino F. Adipose tissue function and dysfunction: organ cross talk and metabolic risk. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E975-E976.
22. Greene M.W., Sakaue H., Wang L., Alessi D.R., Roth R.A. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. J. Biol. Chem. 2003, 278:8199-8211. (Diabetes 48, 1270-1274).
23. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270-1274.
24. Gual P., Le Marchand-Brustel Y., Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87:99-109.
25. Hamilton M.T., Hamilton D.G., Zderic T.W. The role of low energy expenditure and sitting on obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56:2655-2667.
26. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
27. Hotamisligil G.S. Inflammatory pathways and insulin action. Int. J. Obes. 2003, 27(Suppl. 3):S53-S55.
28. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
29. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95:2409-2415.
30. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11:11-18.
31. Kelley D.E., Mokan M., Simoneau J.A., Mandarino L.J. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 1993, 92:91-98.
32. Kim S.H., Reaven G.M. The metabolic syndrome: one step forward, two steps back. Diab. Vasc. Dis. Res. 2004, 1:68-75.
33. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., Shoelson S.E., Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 2001, 108:437-446.
34. Kitamura T., Kitamura Y., Kuroda S., Hino Y., Ando M., Kotani K., Konishi H., Matsuzaki H., Kikkawa U., Ogawa W., Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 1999, 19:6286-6296.
35. Kode J.A., Mukherjee S., Joglekar M.V., Hardikar A.A. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391.
36. Kopelman P.G., Albon L. Obesity, non-insulin-dependent diabetes mellitus and the metabolic syndrome. Br. Med. J. 1997, 53:322-340.
37. Krotkiewski M., Bjorntorp P., Sjostrom L., Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J. Clin. Invest. 1983, 72:1150-1162.
38. Leitges M., Plomann M., Standaert M.L., Bandyopadhyay G., Sajan M.P., Kanoh Y., Farese R.V. Knockout of PKC enhances insulin signaling through PI3K. Mol. Endocrinol. 2002, 16:847-858.
39. Lonnqvist F., Thome A., Nilsell K., Hoffstedt J., Arner P. A pathogenic role of visceral fat P3-adrenoceptors in obesity. J. Clin. Invest. 1995, 95:1109-1116.
40. Madonna R., De Caterina R. In vitro neovasculogenic potential of resident adipose tissue precursors. Am. J. Physiol. Cell Physiol. 2008, 295:C1271-C1280.
41. Madonna R., De Caterina R. Adipose tissue: a new source for cardiovascular repair. J. Cardiovasc. Med. (Hagerstown) 2010, 11:71-80.
42. Madonna R., De Caterina R. Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinema. Rev. Esp. Cardiol. 2012, 65:309-313.
43. Madonna R., Pandolfi A., Massaro M., Consoli A., De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 2004, 47:532-536.
44. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., Matsuzawa Y., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
45. Martin M.L., Jensen M.D. Effects of body fat distribution on regional lipolysis in obesity. J. Clin. Invest. 1991, 88:609-613.
46. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
47. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
48. Pasarica M., Xie H., Hymel D., Bray G., Greenway F., Ravussin E., Smith S.R. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009, 32:900-902.
49. Pedersen S.B. Studies on receptors and actions of steroid hormones in adipose tissue. Dan. Med. Bull. 2005, 52:258.
50. Pirola L., Johnston A.M., Van Obberghen E. Modulation of insulin action. Diabetologia 2004, 47:170-184.
51. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H., American Heart Association, Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 14:898-918.
52. Proud C.G., Wang X., Patel J.V., Campbell L.E., Kleijn M., Li W., Browne G.J. Interplay between insulin and nutrients in the regulation of translation factors. Biochem. Soc. Trans. 2001, 29:541-547.
53. Ravussin E., Smith S.R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 2002, 967:363-378.
54. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 2005, 25:391-406.
55. Rebuffe-Scrive M., Krotkiewski M., Elfverson J., Bjorntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J. Clin. Endocrinol. Metab. 1988, W67:1122-1128.
56. Rebuffe-Scrive M., Andersson B., Olbe L., Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots of non-obese men and women. Metabolism 1989, 38:453-461.
57. Rui L., Aguirre V., Kim J.K., Shulman G.I., Lee A., Corbould A., Dunaif A., White M.F. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 2001, 107:181-189.
58. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
59. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118:2992-3002.
60. Shepherd P.R. Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol. Scand. 2005, 183:3-12.
61. Sierra-Honigmann M.R., Nath A.K., Murakami C., García-Cardeña G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Polverini P.J., Flores-Riveros J.R. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
62. Skolnik E.Y., Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev. 1996, 7:161-173.
63. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Näslund E., Britton T., Concha H., Hassan M., Rydén M., Frisén J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
64. Standaert M.L., Bandyopadhyay G., Galloway L., Soto J., Ono Y., Kikkawa U., Farese R.V., Leitges M. Effects of knockout of the protein kinase C gene on glucose transport and glucose homeostasis. Endocrinology 1999, 140:4470-4477.
65. Stephens J.M., Lee J., Pilch P.F. Tumor necrosis factor-a-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 1997, 272:971-976.
66. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J. Leukoc. Biol. 2010, 88:33-39.
67. Summers S.A., Kao A.W., Kohn A.D., Backus G.S., Roth R.A., Pessin J.E., Birnbaum M.J. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J. Biol. Chem. 1999, 274:17934-17940.
68. Sun X.J., Goldberg J.L., Qiao L.Y., Mitchell J.J. Insulin induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 1999, 48:1359-1364.
69. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., Stewart P.M. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 2004, 25:831-866.
70. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92:347-355.
71. Ward C.W., Lawrence M.C. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 2009, 31:422-434.
72. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
73. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112:1785-1788.
74. White M.F. Insulin signaling in health and disease. Science 2003, 302:1710-1711.
75. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
76. Yudkin J.S. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int. J. Obes. 2003, 27(Suppl. 3):S25-S28.
77. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler. Thromb. Vasc. Biol. 1999, 19:972-978.
78. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., Hedrick, M.H., 2002. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295.